Keros Therapeutics, Inc. (KROS) Stock buybacks 2024–2025
Keros Therapeutics, Inc. (KROS) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$375.0MFY2025 · since FY2024: $0 → $375.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $375.0M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KROS financial trends
KROS RevenueKROS Net incomeKROS Net marginKROS Gross profitKROS Gross marginKROS Operating incomeKROS Operating marginKROS Operating cash flowKROS Free cash flowKROS Capital expendituresKROS Return on equityKROS Dividends paidKROS Total assetsKROS Total liabilitiesKROS Shareholders’ equityKROS overview →